Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 286

1.

A short response time atomic source for trapped ion experiments.

Ballance TG, Goodwin JF, Nichol B, Stephenson LJ, Ballance CJ, Lucas DM.

Rev Sci Instrum. 2018 May;89(5):053102. doi: 10.1063/1.5025713.

PMID:
29864886
2.

Cell cycle-coupled expansion of AR activity promotes cancer progression.

McNair C, Urbanucci A, Comstock CE, Augello MA, Goodwin JF, Launchbury R, Zhao SG, Schiewer MJ, Ertel A, Karnes J, Davicioni E, Wang L, Wang Q, Mills IG, Feng FY, Li W, Carroll JS, Knudsen KE.

Oncogene. 2017 Mar 23;36(12):1655-1668. doi: 10.1038/onc.2016.334. Epub 2016 Sep 26.

3.

Resolved-Sideband Laser Cooling in a Penning Trap.

Goodwin JF, Stutter G, Thompson RC, Segal DM.

Phys Rev Lett. 2016 Apr 8;116(14):143002. doi: 10.1103/PhysRevLett.116.143002. Epub 2016 Apr 6.

4.

DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis.

Goodwin JF, Kothari V, Drake JM, Zhao S, Dylgjeri E, Dean JL, Schiewer MJ, McNair C, Jones JK, Aytes A, Magee MS, Snook AE, Zhu Z, Den RB, Birbe RC, Gomella LG, Graham NA, Vashisht AA, Wohlschlegel JA, Graeber TG, Karnes RJ, Takhar M, Davicioni E, Tomlins SA, Abate-Shen C, Sharifi N, Witte ON, Feng FY, Knudsen KE.

Cancer Cell. 2015 Jul 13;28(1):97-113. doi: 10.1016/j.ccell.2015.06.004.

5.

Beyond DNA repair: DNA-PK function in cancer.

Goodwin JF, Knudsen KE.

Cancer Discov. 2014 Oct;4(10):1126-39. doi: 10.1158/2159-8290.CD-14-0358. Epub 2014 Aug 28. Review.

6.

USP22 regulates oncogenic signaling pathways to drive lethal cancer progression.

Schrecengost RS, Dean JL, Goodwin JF, Schiewer MJ, Urban MW, Stanek TJ, Sussman RT, Hicks JL, Birbe RC, Draganova-Tacheva RA, Visakorpi T, DeMarzo AM, McMahon SB, Knudsen KE.

Cancer Res. 2014 Jan 1;74(1):272-86. doi: 10.1158/0008-5472.CAN-13-1954. Epub 2013 Nov 6.

7.

Control of the conformations of ion Coulomb crystals in a Penning trap.

Mavadia S, Goodwin JF, Stutter G, Bharadia S, Crick DR, Segal DM, Thompson RC.

Nat Commun. 2013;4:2571. doi: 10.1038/ncomms3571.

8.

A hormone-DNA repair circuit governs the response to genotoxic insult.

Goodwin JF, Schiewer MJ, Dean JL, Schrecengost RS, de Leeuw R, Han S, Ma T, Den RB, Dicker AP, Feng FY, Knudsen KE.

Cancer Discov. 2013 Nov;3(11):1254-71. doi: 10.1158/2159-8290.CD-13-0108. Epub 2013 Sep 11.

9.

Targeting cell cycle and hormone receptor pathways in cancer.

Comstock CE, Augello MA, Goodwin JF, de Leeuw R, Schiewer MJ, Ostrander WF Jr, Burkhart RA, McClendon AK, McCue PA, Trabulsi EJ, Lallas CD, Gomella LG, Centenera MM, Brody JR, Butler LM, Tilley WD, Knudsen KE.

Oncogene. 2013 Nov 28;32(48):5481-91. doi: 10.1038/onc.2013.83. Epub 2013 May 27.

10.

Dual roles of PARP-1 promote cancer growth and progression.

Schiewer MJ, Goodwin JF, Han S, Brenner JC, Augello MA, Dean JL, Liu F, Planck JL, Ravindranathan P, Chinnaiyan AM, McCue P, Gomella LG, Raj GV, Dicker AP, Brody JR, Pascal JM, Centenera MM, Butler LM, Tilley WD, Feng FY, Knudsen KE.

Cancer Discov. 2012 Dec;2(12):1134-49. doi: 10.1158/2159-8290.CD-12-0120. Epub 2012 Sep 19.

11.

Punishment of doctors must fit their crime.

Goodwin JF, Somerville W.

BMJ. 1998 Apr 18;316(7139):1248. No abstract available. Erratum in: BMJ 1998 May 30;316(7145):1677.

12.

Sudden cardiac death in the young.

Goodwin JF.

BMJ. 1997 Mar 22;314(7084):843. No abstract available.

13.

Treatment of hypertrophic cardiomyopathy.

Goodwin JF, Oakley CM.

Lancet. 1996 Jan 27;347(8996):261. No abstract available.

PMID:
8551902
14.

A current appreciation of cardiomyopathies.

Goodwin JF.

Acta Cardiol. 1996;51(3):189-202. Review. No abstract available.

PMID:
8817004
15.

Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy.

Goodwin JF, Oakley CM.

Lancet. 1995 Dec 16;346(8990):1624. No abstract available.

PMID:
7500761
17.

ABC of sports medicine. Sudden death in sport.

Hillis WS, McIntyre PD, Maclean J, Goodwin JF, McKenna WJ.

BMJ. 1994 Sep 10;309(6955):657-60. Review. No abstract available.

18.

Ventricular ectopic beats and non-sustained ventricular tachycardia.

Goodwin JF.

Lancet. 1993 Jul 31;342(8866):314. No abstract available.

PMID:
8101350
19.

Honing clinical skills.

Goodwin JF.

Ann Intern Med. 1993 May 15;118(10):828. No abstract available.

PMID:
8297410
20.

Sir John McMichael, 1904-1993.

Goodwin JF.

Clin Cardiol. 1993 May;16(5):453-5. No abstract available.

21.

Screening for hypertrophic cardiomyopathy.

McLatchie GR, Pedoe DS, McKenna WJ, Butler C, Hillis WS, Davies G, Yorath T, Davies MJ, Goodwin JF.

BMJ. 1993 Mar 27;306(6881):860. No abstract available.

22.

Frequency of citation and outcome of cholesterol lowering trials.

Goodwin JF.

BMJ. 1992 Aug 15;305(6850):421; author reply 422. No abstract available.

23.

Preventing coronary heart disease.

Goodwin JF, Sharp I.

BMJ. 1992 Apr 18;304(6833):1057. No abstract available.

24.
25.

The clinical approach--cui bono?

Goodwin JF.

Eur Heart J. 1991 Jul;12(7):751-2. No abstract available.

PMID:
1889437
26.

New serologic marker of cardiac autoimmunity in dilated cardiomyopathy.

Goodwin JF.

J Am Coll Cardiol. 1990 Jun;15(7):1535-6. No abstract available.

27.

Clinical decisions in the management of the cardiomyopathies.

Goodwin JF.

Drugs. 1989 Dec;38(6):988-99. Review.

PMID:
2693049
28.

Surgical treatment of hypertrophic obstructive cardiomyopathy.

McKenna WJ, Goodwin JF, Counihan PJ, Parker DJ, Pepper JR, Ward DE.

Lancet. 1989 Mar 4;1(8636):507. No abstract available.

PMID:
2563885
29.

Programmed stimulation and ventricular fibrillation.

Goodwin JF.

Eur Heart J. 1988 Mar;9(3):343. No abstract available.

PMID:
3383874
30.

Pharmacologic treatment of hypertrophic cardiomyopathy: beta-blockade or calcium blockade or what?

Goodwin JF.

Cardiovasc Drugs Ther. 1988 Mar;1(6):665-8. Review. No abstract available.

PMID:
2908701
31.

Overview and classification of the cardiomyopathies.

Goodwin JF.

Cardiovasc Clin. 1988;19(1):3-7. Review. No abstract available.

PMID:
3048685
32.

Review of hypertrophic cardiomyopathy.

Goodwin JF.

Ergeb Inn Med Kinderheilkd. 1987;55:41-79. Review. No abstract available.

PMID:
3545810
33.

Cardiac transplantation.

Goodwin JF.

Circulation. 1986 Nov;74(5):913-6. No abstract available.

PMID:
3533313
34.

Muscle dynamics in hypertrophic cardiomyopathy.

Alvares RF, Goodwin JF.

Postgrad Med J. 1986 Jun;62(728):545-51.

35.

Professor Goodwin reply.

Goodwin JF.

Br Heart J. 1986 Apr;55(4):418-9. No abstract available.

36.

Urgent coronary artery bypass surgery in the presence of Dressler's syndrome.

Doble N, Westaby S, Goodwin JF.

Clin Cardiol. 1986 Mar;9(3):125-7.

37.

Coronary heart disease and the cardiomyopathies: where are we going?

Goodwin JF.

Can J Cardiol. 1986 Jan-Feb;2(1):1-2. No abstract available.

PMID:
3633747
38.

The challenge and the reproach of infective endocarditis.

Goodwin JF.

Br Heart J. 1985 Aug;54(2):115-8. No abstract available.

39.

Mechanisms in cardiomyopathies.

Goodwin JF.

J Mol Cell Cardiol. 1985 Jul;17 Suppl 2:5-9.

PMID:
2863388
40.

Relation of left ventricular function and prognosis in hypertrophic cardiomyopathy: an angiographic study.

Newman H, Sugrue D, Oakley CM, Goodwin JF, McKenna WJ.

J Am Coll Cardiol. 1985 May;5(5):1064-74.

41.

Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.

McKenna WJ, Oakley CM, Krikler DM, Goodwin JF.

Br Heart J. 1985 Apr;53(4):412-6.

42.
43.

The relationship of myocarditis to dilated cardiomyopathy.

MacArthur CG, Tarin D, Goodwin JF, Hallidie-Smith KA.

Eur Heart J. 1984 Dec;5(12):1023-35.

PMID:
6100098
44.

Cardiology at the crossroads.

Goodwin JF.

Br Heart J. 1984 Nov;52(5):481-3. No abstract available.

45.

Amiodarone for long-term management of patients with hypertrophic cardiomyopathy.

McKenna WJ, Harris L, Rowland E, Kleinebenne A, Krikler DM, Oakley CM, Goodwin JF.

Am J Cardiol. 1984 Oct 1;54(7):802-10.

PMID:
6541429
46.

[Possible relations between viral myocarditis and dilated cardiomyopathy (congestive)].

Goodwin JF.

Recenti Prog Med. 1984 Sep;75(9):833-43. Review. Italian. No abstract available.

PMID:
6096936
47.

Arrhythmias in dilated and hypertrophic cardiomyopathy.

McKenna WJ, Krikler DM, Goodwin JF.

Med Clin North Am. 1984 Jul;68(4):983-1000. Review.

PMID:
6236344
48.

Left ventricular function in patients with ankylosing spondylitis and Reiter's disease.

Ribeiro P, Morley KD, Shapiro LM, Garnett RA, Hughes GR, Goodwin JF.

Eur Heart J. 1984 May;5(5):419-22.

PMID:
6734652
49.

Isovolumic relaxation period in hypertrophic cardiomyopathy.

Alvares RF, Shaver JA, Gamble WH, Goodwin JF.

J Am Coll Cardiol. 1984 Jan;3(1):71-81.

50.

'Pseudo' systolic anterior motion in patients with hypertensive heart disease.

Doi YL, McKenna WJ, Oakley CM, Goodwin JF.

Eur Heart J. 1983 Dec;4(12):838-45.

PMID:
6686523

Supplemental Content

Loading ...
Support Center